Navigation Links
Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
Date:10/15/2007

Accellerase(TM) 1000 is launched at the Cellulosic Ethanol Summit in

Washington, DC

ROCHESTER, N.Y., Oct. 15 /PRNewswire/ -- Genencor, a division of Danisco A/S, today announced a new product, Accellerase(TM) 1000, the first ever commercially available biomass enzyme developed specifically for second generation biorefineries. Accellerase(TM) 1000 contains a potent complex of enzymes that reduces complex lignocellulosic biomass into fermentable sugars -- an indispensable step for the production of cellulosic ethanol.

Genencor has been developing its biomass enzymes for well over 10 years. The effort was partially supported by contracts with the US Department of Energy's (DOE) National Renewable Energy Laboratory (NREL). Commercial interest in second generation biorefineries, driven in part by government policies to reduce the emission of greenhouse gases and increase energy independence, has accelerated over the past two years in the USA and around the world. Accellerase(TM) 1000 will fill a large unmet need for reliable biomass enzyme supply to pilot and demonstration plant developers who are actively working on process development, scale up and integration. Accellerase(TM) 1000 is the first in what the company expects to be a family of products tailored to different biomass feedstocks and system conditions. The key features that are expected to be important at commercial scale are already built into this first product.

"The biofuels industry is at an inflection point with the development of cellulosic ethanol plants at the pilot and demonstration scale," said Jack Huttner, vice president of biorefinery business development. "Every biorefinery developer needs to know how enzymes will work in their system. This product aims to address that need and to start a dialogue with potential partners about customized solutions and supply at the industrial scale."

"Enzymes, such as those developed by Genencor, wi
'/>"/>

SOURCE Genencor
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNewsw...blisher of scientific, medical and technical produ...h of Embase, its comprehensive biomedical,database...more than 7,000,active, peer reviewed journals. ,...advancement of new biomedical,and pharmaceutical i...
(Date:11/27/2009)... November 27 Stallergene...lair(R) in both adults and children,through a Mutu...ry where,Oralair(R) has been marketed, was the ref...registered in Austria, Belgium, Bulgaria, Cyprus, ...ce, Hungary, Ireland, Italy,Latvia, Lithuania, Lu...
(Date:11/25/2009)...ON, Nov. 25 Biotech firm Replikins...data from the 1918 pandemic through the prediction...mic, today issued its latest biochemical analysis ...y of the H1N1 ("Swine Flu") virus has dropped from...rent outbreak in the spring of 2009 to resting non...
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Bio... of vaccines, announced today that it executed,a j...Dalian) Vaccine,Technology Co., Ltd. (Sinovac Dali...mmercialize human-use vaccines. Sinovac will contr...nd commercializing world-class vaccines; the,other...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
... Computers aren,t very good at tolerating unexpect...ractable when they encounter a spike in their powe...stream. They,re a little like us that way. The dif...wn intractability, assuming we recognize it and ch... about people who begin to look like their pets. D...
... The global pharmaceutical market failed to reach ...about nine years. Key reasons for this focused on ... from generic drugs as major products had their pa...et did. This is according to the estimates of IMS ... ,If the overall growth of the pharmaceutical mark...
... In the halls of Congress as well as the Wisconsin...e opponents of human embryonic stem cell research ...unethical. The fight over stem-cell research is fa... merits is beginning to carry more weight. , ,Foll...nd the promise of science, the House of Representa...
Other Biology Technology:Machine like me 2Machine like me 3Though pharma growth slides, blockbusters reach new record 2Though pharma growth slides, blockbusters reach new record 3With ethics guidelines, political consensus emerging on stem-cell research 2With ethics guidelines, political consensus emerging on stem-cell research 3
(Date:11/30/2009)...am overcame a major hurdle plaguing the developmen...o more efficient catalysts used to produce hydroge...rs reported Nov. 29 in Nature Materials the firs...etallic nanoparticles, the vaunted next-generation...heat. , Gtz Veser, an associate professor and CN...
(Date:11/30/2009)...ntal Biology are pleased to announce that Dr Xavi...entifique (CNRS) in the Universit de Nice-Sophia-A...nding Paper Prize. ,The prize is awarded in recogn...d to encourage young scientists, says Hans Hopple...truly appreciate when authors submit their very be...
(Date:11/30/2009)...stration rates and register online now for the pre....iofwco-ecceo10.org/ , WHAT: IOF WCO-ECCEO10 i...is Foundation (IOF) and the European Society for C...steoarthritis (ESCEO). More than 5,000 participant...e exciting scientific programme includes 12 plenar...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Scientists Reverse Multiple Sclerosis in Mice 54342 1Scientists Reverse Multiple Sclerosis in Mice 54342 2CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 54339 1CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 54339 2CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 54339 3OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 1OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 2OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 3
... Mayo Clinic research team has challenged the acce...in which the body,s cells generate fever, shock an...sons from bacterial infection interfere with the c...eld concept with a new theory in an opinion piece ...ne http://www.sciencedirect.com/science/journal/1...
...arwinian evolution follows very few of the availab...researchers at Harvard University have found in a ...ial resistance to a widely prescribed antibiotic b...s that of 120 harrowing, five-step mutational path...ance, only about 10 actually endow bacteria with a...
...he Gulf of Maine Program of the Census of Marine L.... Andrews, New Brunswick, announced today the firs...ne region -- more than 50% larger than previous es...es both year-round species and those that migrate ... is part of the international Census of Marine Lif...
Other Biology News:Mayo Clinic researchers challenge sepsis theory 2Mayo Clinic researchers challenge sepsis theory 3Evolution follows few of the possible paths to antibiotic resistance 2The diversity of marine life in the Gulf of Maine region is much greater than previously thought 2The diversity of marine life in the Gulf of Maine region is much greater than previously thought 3The diversity of marine life in the Gulf of Maine region is much greater than previously thought 4The diversity of marine life in the Gulf of Maine region is much greater than previously thought 5
Mouse Anti-Human Complement factor B Monoclonal Antibody, Unconjugated, Clone 9B6 from AntibodyShop A/S
...ransduction cascade is one of three identified MAP...n occurs in response to environmental stress, is a...elf, and is implicated in the immune response, cel...phogenesis, and apoptosis.JIP1 (JNK-interacting pr...
...rared range FT-IR spectrometers give you the only ...et all this comes at an amazingly affordable price...larger and faster mirror closer to the source comp...rger solid angle of energy into the interferometer...
...e three fluorescence lifetimespicoseconds to secon...match the absorption maxima of the amino acids tyr...on source is the powerful NanoLED-17, a pulsed dio...widely used as a probe of protein structure and dy...
Biology Products: